Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro
- 1 January 1979
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 28 (3), 345-350
- https://doi.org/10.1016/0006-2952(79)90096-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersEuropean Journal of Cancer (1965), 1978
- Some antitumor derivatives of ellipticine deprived of mutagenic propertiesChemico-Biological Interactions, 1977
- Effects of 9-hydroxyellipticine on growth and macromolecular synthesis inEscherichia coliFEBS Letters, 1976
- Association of mammalian cell death with a specific endonucleolytic degradation of DNANature, 1974
- A New Antitumoral Agent: 9-Hydroxyellipticine. Possibility of a Rational Design of Anticancerous Drugs in the Series of DNA Intercalating DrugsProceedings of the National Academy of Sciences of the United States of America, 1974
- Actinomycin D-induced breakage of human KB cell DNANature, 1974
- Biochemical effects of ellipticine on leukemia L1210 cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1974
- Strand-scission of HeLa cell deoxyribonucleic acid by bleomycin in vitro and in vivoBiochemical Pharmacology, 1973
- A new DNA intercalating drug: Methoxy‐9‐ellipticineFEBS Letters, 1971
- Synthesis of the tumour-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazolesAustralian Journal of Chemistry, 1967